BRITTANY SPAULDING: Open Payments
NPI 1194310615 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 9 payments from 6 companies in 2025. Trend: 2023 $187 · 2024 $614 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $125 |
| Novartis Pharmaceuticals Corporation | 1 | $124 |
| GENZYME CORPORATION | 3 | $57 |
| Novo Nordisk Inc | 1 | $42 |
| Medtronic, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: DUPIXENT, Wegovy, PROPEL, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
